Current Infectious Disease Reports最新文献_第7页

Early Empirical Use of Broad-Spectrum Antibiotics in Sepsis 广谱抗生素在脓毒症中的早期经验应用

IF 3.1 4区医学

Current Infectious Disease Reports Pub Date : 2022-03-30 DOI: 10.1007/s11908-022-00777-2

Jonathan L. Chang, J. Pearson, C. Rhee

引用次数: 1

Influential Papers that Shaped Paradigms and Changed Practice in Infection Prevention in the Last 60 Years: Then, Now, and Future Directions 在过去的60年里，有影响力的论文塑造了感染预防的范式和改变了实践:过去，现在和未来的方向

IF 3.1 4区医学

Current Infectious Disease Reports Pub Date : 2022-02-01 DOI: 10.1007/s11908-022-00775-4

Laura Pedersen, G. Bearman, M. Kiernan, M. Rupp

引用次数: 0

Loop-Mediated Isothermal Amplification-Based Microfluidic Platforms for the Detection of Viral Infections. 基于环介导等温扩增的病毒感染检测微流控平台。

IF 3.1 4区医学

Current Infectious Disease Reports Pub Date : 2022-01-01 DOI: 10.1007/s11908-022-00790-5

Yuanyuan Zeng, Chuan Wu, Yang He

{"title":"Loop-Mediated Isothermal Amplification-Based Microfluidic Platforms for the Detection of Viral Infections.","authors":"Yuanyuan Zeng, Chuan Wu, Yang He","doi":"10.1007/s11908-022-00790-5","DOIUrl":"https://doi.org/10.1007/s11908-022-00790-5","url":null,"abstract":"Purpose of review: Easy-to-use, fast, and accurate virus detection method is essential for patient management and epidemic surveillance, especially during severe pandemics. Loop-mediated isothermal amplification (LAMP) on a microfluidic platform is suitable for detecting infectious viruses, regardless of the availability of medical resources. The purpose of this review is to introduce LAMP-based microfluidic devices for virus detection, including their detection principles, methods, and application.Recent findings: Facing the uncontrolled spread of viruses, the large-scale deployment of LAMP-based microfluidic platforms at the grassroots level can help expand the coverage of nucleic acid testing and shorten the time to obtain test reports. Microfluidic chip technology is highly integrated and miniaturized, enabling precise fluid control for effective virus detection. Performing LAMP on miniaturized systems can reduce analysis time, reagent consumption and risk of sample contamination, and improve analytical performance.Summary: Compared to traditional benchtop protocols, LAMP-based microfluidic devices reduce the testing time, reagent consumption, and the risk of sample contamination. In addition to simultaneous detection of multiple target genes by special channel design, microfluidic chips can also integrate digital LAMP to achieve absolute quantification of target genes.","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628606/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10359557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

Chikungunya: An Emerging Public Health Concern. 基孔肯雅热:一个新出现的公共卫生问题。

IF 3.1 4区医学

Current Infectious Disease Reports Pub Date : 2022-01-01 DOI: 10.1007/s11908-022-00789-y

Omar Mourad, Leila Makhani, Lin H Chen

{"title":"Chikungunya: An Emerging Public Health Concern.","authors":"Omar Mourad, Leila Makhani, Lin H Chen","doi":"10.1007/s11908-022-00789-y","DOIUrl":"https://doi.org/10.1007/s11908-022-00789-y","url":null,"abstract":"Purpose of review: The worldwide spread of chikungunya over the past two decades calls for greater knowledge and awareness of the virus, its route of transmission, methods of diagnosis, and the use of available treatment and prevention measures.Recent findings: Chikungunya virus infection, an Aedes mosquito-borne febrile disease, has spread from Africa and Asia to Europe and the Americas and from the tropics and subtropics to temperate regions. International travel is a pivotal influence in the emergence of chikungunya as a global public health threat, as evidenced by a growing number of published reports on travel-related chikungunya infections. The striking features of chikungunya are arthralgia and arthritis, and the disease is often mistaken for dengue. Although mortality is low, morbidity can be profound and persistent. Current treatment for chikungunya is supportive; chikungunya vaccines and therapeutics are in development. Travelers planning to visit areas where the mosquito vectors are present should be advised on preventive measures.Summary: Chikungunya is an emerging disease in the Americas. Frequent travel, the presence of at least two competent mosquito species, and a largely naïve human population in the Western Hemisphere create a setting conducive to future outbreaks. Awareness of the disease and its manifestations is critical to effectively and safely manage and limit its impact. Vaccines in late-stage clinical trials offer a new pathway to prevention.","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672624/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10736923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 9

COVID-19 Infection in Children: Diagnosis and Management. 儿童新冠肺炎感染的诊断与管理

IF 3.1 4区医学

Current Infectious Disease Reports Pub Date : 2022-01-01 Epub Date: 2022-04-11 DOI: 10.1007/s11908-022-00779-0

Frank Zhu, Jocelyn Y Ang

{"title":"COVID-19 Infection in Children: Diagnosis and Management.","authors":"Frank Zhu, Jocelyn Y Ang","doi":"10.1007/s11908-022-00779-0","DOIUrl":"10.1007/s11908-022-00779-0","url":null,"abstract":"Purpose of review: Due to the rapidly changing landscape of COVID-19, the purpose of this review is to provide a concise and updated summary of pediatric COVID-19 diagnosis and management.Recent findings: The relative proportion of pediatric cases have significantly increased following the emergence of the Omicron variant (from < 2% in the early pandemic to 25% from 1/27 to 2/3/22). While children present with milder symptoms than adults, severe disease can still occur, particularly in children with comorbidities. There is a relative paucity of pediatric data in the management of COVID-19 and the majority of recommendations remain based on adult data.Summary: Fever and cough remain the most common clinical presentations, although atypical presentations such as \"COVID toes,\" anosmia, and croup may be present. Children are at risk for post-infectious complications such as MIS-C and long COVID. Nucleic acid amplification tests through respiratory PCR remain the mainstay of diagnosis. The mainstay of management remains supportive care and prevention through vaccination is highly recommended. In patients at increased risk of progression, interventions such as monoclonal antibody therapy, PO Paxlovid, or IV remdesivir × 3 days should be considered. In patients with severe disease, the use of remdesivir, dexamethasone, and immunomodulatory agents (tocilizumab, baricitinib) is recommended. Children can be at risk for thrombosis from COVID-19 and anticoagulation is recommended in children with markedly elevated D-dimer levels or superimposed clinical risk factors for hospital associated venous thromboembolism.","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996502/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46294412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Preventing Hemodialysis Catheter-Related Bloodstream Infections: Barriers, Controversies, and Best Practices 预防血液透析导管相关的血流感染：障碍、争议和最佳实践

IF 3.1 4区医学

Current Infectious Disease Reports Pub Date : 2022-01-01 DOI: 10.1007/s11908-022-00773-6

Ryan Wooten, Devki Kothari, R. Pryor, G. Bearman

引用次数: 1

Nosocomial Extracardiac Infections After Cardiac Surgery. 心脏手术后医院外感染。

IF 3.1 4区医学

Current Infectious Disease Reports Pub Date : 2022-01-01 DOI: 10.1007/s11908-022-00787-0

Enrico Maria Zardi, Massimo Chello, Domenico Maria Zardi, Raffaele Barbato, Omar Giacinto, Ciro Mastoianni, Mario Lusini

{"title":"Nosocomial Extracardiac Infections After Cardiac Surgery.","authors":"Enrico Maria Zardi, Massimo Chello, Domenico Maria Zardi, Raffaele Barbato, Omar Giacinto, Ciro Mastoianni, Mario Lusini","doi":"10.1007/s11908-022-00787-0","DOIUrl":"https://doi.org/10.1007/s11908-022-00787-0","url":null,"abstract":"Purpose of review: Nosocomial extracardiac infections after cardiac surgery are a major public health issue affecting 3-8.2% of patients within 30-60 days following the intervention.Recent findings: Here, we have considered the most important postoperative infective complications that, in order of frequency, are pneumonia, surgical site infection, urinary tract infection, and bloodstream infection. The overall picture that emerges shows that they cause a greater perioperative morbidity and mortality with a longer hospitalization time and excess costs. Preventive interventions and corrective measures, diminishing the burden of nosocomial extracardiac infections, may reduce the global costs. A multidisciplinary team may assure a more appropriate management of nosocomial extracardiac infections leading to a reduction of hospitalization time and mortality rate.Summary: The main and most current data on epidemiology, prevention, microbiology, diagnosis, and management for each one of the most important postoperative infective complications are reported. The establishment of an antimicrobial stewardship in each hospital seems to be, at the moment, the more valid strategy to counteract the challenging problems.","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510267/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10367484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Correction to: Les misérables: A Parallel Between Antimicrobial Resistance and COVID‑19 in Underdeveloped and Developing Countries. 更正:Les mismisrables:不发达国家和发展中国家抗菌素耐药性与COVID - 19之间的相似性。

IF 3.1 4区医学

Current Infectious Disease Reports Pub Date : 2022-01-01 DOI: 10.1007/s11908-022-00791-4

Genesy Pérez Jorge, Isabella Carolina Rodrigues Dos Santos Goes, Marco Tulio Pardini Gontijo

引用次数: 0

Integrase Inhibitors Use for HIV Infection in Pregnancy 整合酶抑制剂用于妊娠期HIV感染

IF 3.1 4区医学

Current Infectious Disease Reports Pub Date : 2022-01-01 DOI: 10.1007/s11908-022-00774-5

Sávio Amaral, C. Brites, E. Sprinz

引用次数: 1

Mechanical Circulatory Support Infections in Heart Transplant Candidates 心脏移植患者的机械循环支持感染

IF 3.1 4区医学

Current Infectious Disease Reports Pub Date : 2022-01-01 DOI: 10.1007/s11908-022-00772-7

R. Fuller, S. Taimur, E. Baneman

引用次数: 1